Medication Adherence in Greek Hemodialysis Patients: The Contribution of Depression and Health Cognitions
- 537 Downloads
Several studies have shown that non-adherence is a common and increasing problem among individuals with chronic illnesses, including hemodialysis patients.
The present study aimed to investigate the influence of depression and health cognitions on medication adherence among patients undergoing hemodialysis.
A sample of 168 participants was recruited from six general hospitals in the broader area of Athens, consisting of patients undergoing in-center hemodialysis. Measurements were conducted with the following instruments: the Medication Adherence Rating Scale, the Center for Epidemiologic Studies Depression Scale (CES-D), and the Multidimensional Health Locus of Control (MHLC) scale.
The results indicated that medication adherence was associated positively with the dimensions of internal and doctor-attributed health locus of control, measured by the MHLC. It was also related negatively to depression, measured by the CES-D.
The present study demonstrates the importance of depression in understanding the medication adherence of hemodialysis patients, as well as the contribution of heath cognitions.
KeywordsAdherence Medication Hemodialysis Depression Health cognitions
The author would like to thank the patients for their participation in the study and acknowledge the support given by the health professionals and the administration personnel of the participating dialysis units.
- 2.Theofilou P. Sexual functioning in chronic kidney disease: the association with depression and anxiety. Hemodial Int. 2011. doi: 10.1111/j.1542-4758.2011.00585.x.
- 3.Theofilou P. Depression and anxiety in patients with chronic renal failure: the effect of sociodemographic characteristics. Int. J. Nephrol. 2011; 1-6.Google Scholar
- 5.Theofilou P. The relation of social support to mental health and locus of control. J Renal Nurs. 2012;4:18–22.Google Scholar
- 6.Theofilou P. Self-esteem in Greek dialysis patients: the contribution of health locus of control. Iran J Kidney Dis. 2012;6:2.Google Scholar
- 9.Theofilou P. Non-compliance with medical regimen in haemodialysis treatment: a case study. Case Reports in Nephrology 2011; 1–4.Google Scholar
- 10.Sabate E. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003.Google Scholar
- 11.Haynes R, Ackloo E, Sahota N, McDonald H. Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2) 2008; CD000011.Google Scholar
- 14.Theofilou P. Quality of life and mental health in haemodialysis and peritoneal dialysis patients: the role of health beliefs. Int Urol Nephrol. 2011e. doi: 10.1007/s11255-011-9975-0.
- 19.Axelsson M. Personality and adherence to medication treatment. Sweden: Intellecta Infolog AB; 2011.Google Scholar
- 30.Azlin B, Hatta S, Norzila Z, Sharifa Ezat WP. Health locus of control among non-compliance hypertensive patients undergoing pharmacotherapy. Malays J Psychiatry. 2007;16:20–39.Google Scholar
- 32.Akman B, Uyar M, Afsar B. Adherence, depression and quality of life in patients on a renal transplantation waiting list. Transpl Int. 2007;5:1–6.Google Scholar
- 34.Meyers KR. Religiosity and health locus of control as predictors of depression and anxiety in women with breast cancer. ETD Collection for Fordham University. 2002; Paper AAI3056149 http://fordham.bepress.com/dissertations/AAI3056149
- 36.Moreira L, Fernandes P, Monte S, Martins A. Adesão ao tratamento farmacológico em pacientes com doença renal crônica. J Bras Nefrol. 2008;30:113–9.Google Scholar
- 41.Theofilou P, Geitona M. Comparative study of bicarbonate dialysis and haemodiafiltration in end-stage renal disease. Farmacoeconomics. 2008;36:5–11.Google Scholar
- 44.Combs DL, O’Brien RJ, Geiter LJ. Compliance with tuberculosis regimes: results from USPHS therapy trial 21. Am Rev Respir Dis. 1987;135:138.Google Scholar
- 45.International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60:556–64.Google Scholar